NMUS don't say a gift was never offered up with this Cali Mj! The whole board full of players from multi-billion $ companies

tweeted it

THC THERAPEUTICS will not be merging with $GOFF.
Will become very clear why soon. You all will understand. We still are going public!!!!👍👍

— Brandon Romanek (@brandonromanek) October 24, 2016

its pretty black and white when the CEO says that THC WILL not be merging with GOFF...its back to an old APS shell once again

you mean the one that has been pumped by low budget promoters for over a year? Puke, gag, barf.

its very impressive and I realise the name change reflected their expanded focus into bio and it will pay off in future I'm sure, but otc traders are fickle and creatures of habit. I'm sure the stock would have run much higher if it was still CANV

don't worry, you are talking my language and I considered CVSI the best fundamental MJ stock in otc/pink world a long time ago...I've been swinging since 0.27 (plenty of tweets to back that up too)

in terms of tradeability that relationship applies, in terms of cap, its the equivalent of about $45 at todays o/s. I'd say realistically be happy to see a run to $5! ha

went to like $210 (under ticker CANV) - float was like 8m then compared to 28m now

ACOL MJ California news: Partnership Between Acology and Kush Shows Early Momentum

October 24, 2016 8:30 AM
CORONA, CA -- (Marketwired) -- 10/24/16 -- The announcement on September 20 of the partnership between Acology Inc. (OTC PINK: ACOL) and Kush Bottles (OTCQB: KSHB) sent shockwaves through the cannabis packaging industry and created stock gains for both companies as the US moves toward the pivotal November election. California is now expected to ratify Prop.64, legalizing cannabis for recreational use and sending orders for compliant packaging soaring.

Nicholas Kovacevich, Co-Founder and Chief Executive Officer of Kush Bottles, said, "The MedTainer™ is a great addition to our growing portfolio of customizable products, which have been shown to create a steady stream of recurring revenue, as customers typically reorder customized products. The MedTainer™ was particularly appealing to us because our customers can use it as a promotional giveaway or accessory cross-sell to help build their brand. Our customers can use this product as a premium packaging solution or continue to purchase other forms of branded packaging, such as barrier bags or labels, while ordering custom MedTainers as a promotional item," concluded Mr. Kovacevich.

Acology's signature product, the MedTainer™, has been gaining traction with sales exceeding expectations for calendar 2016. In addition to the revenues generated by customizing and branding MedTainers, as the states that are positioning for legalization begin to codify compliant packaging regulations, including certified child-resistance, proper labeling and product track-ability, the MedTainer™ is seen as the perfect packaging solution for cannabis end-users.

The MedTainer's certificate for child-resistance comes from Child Related Research Inc. in Murray, Utah. Accredited here in the US and internationally, and given an A+ rating by the BBB, CRR Inc. gave a rare 100% rating to the MedTainer™ along with its Child-Resistance Certificate.

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company's websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send any and all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649).

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

ACOL Partnership Between Acology and Kush Shows Early Momentum

October 24, 2016 8:30 AM
CORONA, CA -- (Marketwired) -- 10/24/16 -- The announcement on September 20 of the partnership between Acology Inc. (OTC PINK: ACOL) and Kush Bottles (OTCQB: KSHB) sent shockwaves through the cannabis packaging industry and created stock gains for both companies as the US moves toward the pivotal November election. California is now expected to ratify Prop.64, legalizing cannabis for recreational use and sending orders for compliant packaging soaring.

Nicholas Kovacevich, Co-Founder and Chief Executive Officer of Kush Bottles, said, "The MedTainer™ is a great addition to our growing portfolio of customizable products, which have been shown to create a steady stream of recurring revenue, as customers typically reorder customized products. The MedTainer™ was particularly appealing to us because our customers can use it as a promotional giveaway or accessory cross-sell to help build their brand. Our customers can use this product as a premium packaging solution or continue to purchase other forms of branded packaging, such as barrier bags or labels, while ordering custom MedTainers as a promotional item," concluded Mr. Kovacevich.

Acology's signature product, the MedTainer™, has been gaining traction with sales exceeding expectations for calendar 2016. In addition to the revenues generated by customizing and branding MedTainers, as the states that are positioning for legalization begin to codify compliant packaging regulations, including certified child-resistance, proper labeling and product track-ability, the MedTainer™ is seen as the perfect packaging solution for cannabis end-users.

The MedTainer's certificate for child-resistance comes from Child Related Research Inc. in Murray, Utah. Accredited here in the US and internationally, and given an A+ rating by the BBB, CRR Inc. gave a rare 100% rating to the MedTainer™ along with its Child-Resistance Certificate.

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company's websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send any and all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649).

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

ACOL Partnership Between Acology and Kush Shows Early Momentum

October 24, 2016 8:30 AM
CORONA, CA -- (Marketwired) -- 10/24/16 -- The announcement on September 20 of the partnership between Acology Inc. (OTC PINK: ACOL) and Kush Bottles (OTCQB: KSHB) sent shockwaves through the cannabis packaging industry and created stock gains for both companies as the US moves toward the pivotal November election. California is now expected to ratify Prop.64, legalizing cannabis for recreational use and sending orders for compliant packaging soaring.

Nicholas Kovacevich, Co-Founder and Chief Executive Officer of Kush Bottles, said, "The MedTainer™ is a great addition to our growing portfolio of customizable products, which have been shown to create a steady stream of recurring revenue, as customers typically reorder customized products. The MedTainer™ was particularly appealing to us because our customers can use it as a promotional giveaway or accessory cross-sell to help build their brand. Our customers can use this product as a premium packaging solution or continue to purchase other forms of branded packaging, such as barrier bags or labels, while ordering custom MedTainers as a promotional item," concluded Mr. Kovacevich.

Acology's signature product, the MedTainer™, has been gaining traction with sales exceeding expectations for calendar 2016. In addition to the revenues generated by customizing and branding MedTainers, as the states that are positioning for legalization begin to codify compliant packaging regulations, including certified child-resistance, proper labeling and product track-ability, the MedTainer™ is seen as the perfect packaging solution for cannabis end-users.

The MedTainer's certificate for child-resistance comes from Child Related Research Inc. in Murray, Utah. Accredited here in the US and internationally, and given an A+ rating by the BBB, CRR Inc. gave a rare 100% rating to the MedTainer™ along with its Child-Resistance Certificate.

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company's websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send any and all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649).

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

one source a year ago claims that...and fwiw, CVSI is same tier and CEO already stated plans to uplist for next year.

See you at the finish line.

CVSI will get to big boards well before OWCP ever does IMH - its probably the best otc/pinksheet MJ play out there on paper if you look at income statement and balance sheet

NMUS California MJ could be crazy long term potential and totally off mainstream radar (woke up yesterday). CEO calls them the US GWPH, sole partner with U of Miss who is the sole provider of marijuana for medical research. o/s19.9m float is 5.9m so crazy thin. Break $1 and it runs hard IMH

DD
http://www.safeaccessnow.org/nemus_bioscience_to_develop_marijuana_pharmaceuticals

http://www.biomedreports.com/articles/featured-content/271897-new-class-of-medicinals-based-on-cannabinoid-molecules-spurs-nemus-bioscience-inc-into-action.html

http://www.ocregister.com/articles/marijuana-725707-cannabis-drugs.html?utm_content=bufferd5ef0&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer

Older background interview here https://vimeo.com/118708769

NMUS California MJ could be crazy long term potential and totally off mainstream radar (woke up yesterday). CEO calls them the US GWPH, sole partner with U of Miss who is the sole provider of marijuana for medical research. o/s19.9m float is 5.9m so crazy thin. Break $1 and it runs hard IMH

DD
http://www.safeaccessnow.org/nemus_bioscience_to_develop_marijuana_pharmaceuticals

http://www.biomedreports.com/articles/featured-content/271897-new-class-of-medicinals-based-on-cannabinoid-molecules-spurs-nemus-bioscience-inc-into-action.html

http://www.ocregister.com/articles/marijuana-725707-cannabis-drugs.html?utm_content=bufferd5ef0&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer

Older background interview here https://vimeo.com/118708769

NMUS MJ California play that could be crazy long term potential and totally off mainstream radar (woke up yesterday). CEO calls them the US GWPH, sole partner with U of Miss who is the sole provider of marijuana for medical research.

o/s 19.9m float is 5.9m so crazy thin. Break $1 and it runs hard IMH

DD
http://www.safeaccessnow.org/nemus_bioscience_to_develop_marijuana_pharmaceuticals

http://www.biomedreports.com/articles/featured-content/271897-new-class-of-medicinals-based-on-cannabinoid-molecules-spurs-nemus-bioscience-inc-into-action.html

http://www.ocregister.com/articles/marijuana-725707-cannabis-drugs.html?utm_content=bufferd5ef0&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer

NMUS could be crazy long term potential and totally off mainstream radar (woke up yesterday). CEO calls them the US GWPH, sole partner with U of Miss who is the sole provider of marijuana for medical research. o/s19.9m float is 5.9m so crazy thin. Break $1 and it runs hard IMH

DD
http://www.safeaccessnow.org/nemus_bioscience_to_develop_marijuana_pharmaceuticals

http://www.biomedreports.com/articles/featured-content/271897-new-class-of-medicinals-based-on-cannabinoid-molecules-spurs-nemus-bioscience-inc-into-action.html

http://www.ocregister.com/articles/marijuana-725707-cannabis-drugs.html?utm_content=bufferd5ef0&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer

that includes insiders

investor is not going to convert for 0.5 when its barely above and converting to common and selling runs risk of not making money! They are just going to ride it out to the end, OR if the price is much higher (ie, north $1) to reduce the risk of not making decent gains by selling the blocks.

Regardless, end of November a long way away and non-issue in my books.

less than that based on http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11590593

52.3m o/s, then I get 24.3m insider as per:

Mai Dun Limited (3) 5,463,162
Mackay Ventures, LLC (4) 6,027,094
James J. Mahoney (5) 4,502,165
Rhonda Mona (6) 3,824,164
Michael Mona III (7) 2,405,373
Joseph Dowling (8) 464,582
Michael Mona, Jr. (9) 6,000,000
Bart Mackay (10) 6,256,726
Larry Raskin (11) 668,332
James McNulty (12) 133,333
Gary Sligar(13) 83,333

(exclude Mackay Ventures/Mai Dun as they are duplicate entries based on Bart Mackays total)

That leaves only 28m float.

Now since then, there are 7.5m that will get added to O/S based on exercise of options for Mona Jr, but only if exercised AND that would likely still be insider and the float wont change.

ACOL needs to be looked at. Totally unfollowed just got through trip zero today and really 'stumbled' onto usage for the MJ industry similar to AERO. This was further confirmed when they recently announced deal with Kush Bottles (KSHB). http://finance.yahoo.com/news/kush-bottles-partners-acology-bring-101700742.html

Kush already have their products set up on website here: http://www.customcannabispackaging.com/medtainer/

Key thing though is growth and revenues - they grew over 200% last year to 1.4 million and this year are on pace to grow another 40-50%. That's a trip zero essentially with more revenue than 95% of all the pot plays out there IMH

Dilution not a major problem either - they do have a pile of shares out 5 billion, but float is 700m. Dilution has been 500 mil in last 2 years and this does trade very thin.

Biggest angle I like, they are in California - the hot box going into the elections, and there were always 'concerned' about the MJ angle as they didn't want to be labelled as drug paraphernalia. Legalising will totally change that and open up way more opportunities.

Certainly ground floor still and worth a serious look IMH

ACOL needs to be looked at. Totally unfollowed just got through trip zero today and really 'stumbled' onto usage for the MJ industry similar to AERO. This was further confirmed when they recently announced deal with Kush Bottles (KSHB). http://finance.yahoo.com/news/kush-bottles-partners-acology-bring-101700742.html

Kush already have their products set up on website here: http://www.customcannabispackaging.com/medtainer/

Key thing though is growth and revenues - they grew over 200% last year to 1.4 million and this year are on pace to grow another 40-50%. That's a trip zero essentially with more revenue than 95% of all the pot plays out there IMH

Dilution not a major problem either - they do have a pile of shares out 5 billion, but float is 700m. Dilution has been 500 mil in last 2 years and this does trade very thin.

Biggest angle I like, they are in California - the hot box going into the elections, and there were always 'concerned' about the MJ angle as they didn't want to be labelled as drug paraphernalia. Legalising will totally change that and open up way more opportunities.

Certainly ground floor still and worth a serious look IMH

ACOL pot play 0.0011 - recent deal with KSHB and very legit just coming out of the triples - expecting 2m in revenue this year and huge potential as more and more states are legalized

what are you talking about with MCOA? They are full reporting?

USRM getting action off of STEM craziness at 0.03 - only 14m o/s and trading 0.2x sales

probably an annual one time 4/20 thing where they get the big pop in revenues. Expect next Q to be much lower IMH while losses will stay high.

not 'they', ihub from the looks of it

this was the official headline

Appiphany Technologies Announces New Annual Contract for TOMS Shoes

got pumped as a 900 million dolla contract...nothing more

lol, for 1, that is outdated already and the updated number is 60,400. For 2, do the math! Under $5k has no effect in grand scheme of things.

If I recall, they already sold the rights to the brand and all their inventory - there is nothing here but a shell and some debt still.

If a plan cannot be confirmed, the court may either convert the case to a liquidation under chapter 7, or, if in the best interests of the creditors and the estate, the case may be dismissed resulting in a return to the status quo before bankruptcy. If the case is dismissed, creditors will look to non-bankruptcy law in order to satisfy their claims.

Translation, any debt remaining for DLIAQ is still remaining, there is nothing good that came out of this. Doesn't matter anyway since they already liquidated and don't even have rights to the brand anymore.

shares of a shell....sure

do you understand fundamentals at all? They just reported 10m revenue, they anticipate 20m revenue 2016, even being generous and giving them 25m, that doesn't make the company worth more than 1/2 a billion.
A 'fair' generous valuation is around 20c which would value it at 100m....anything beyond that is and has been just typical otc hype hype hype

no - first 500 get free grab bags and free tacos if you buy in store. Of course giving stuff away creates lineups.

GRNH went from 4c to $1.20 in 5 days back in 2014 - that was on 60m float at the time and it pushed over 60m in volume daily at the peak. Back then was just speculation, now they are starting to produce and Q1 revenue exceeds all of last year.

wow....

I am refering to the location of the dispensary...

not the way they pumped it though:

1921 Western Avenue and is expected to benefit from the heavy traffic in Las Vegas.

that statement is crap

I realize of course down the road, recreation is the big thing, but there was alot of hype for 'las vegas strip' and that couldn't be further from the truth. They could have picked anywhere in any large city and been better off than this location. I think too many got blinded thinking 'heavy traffic' of the strip not realizing this location is worse than most. The company is misleading there.

Not exactly hopping and inviting: https://goo.gl/maps/LpPqfx8hA3L2

then it can compete with piles of other dispensaries. My only point is to pump LV strip is extremely misleading as that location has zero foot traffic. Hell, it doesn't even have any sidewalks! Tourists wont be drawn there, even with a shuttle (inconvenience) - if they want to go, they'll just take a taxi IMH

grand opening will mean squat - crappy location, no foot traffic (especially from tourists), tons of competitors all around.

Just saying. Here's typical 'reality':

http://www.ibtimes.com/medical-marijuana-has-arrived-las-vegas-will-all-rules-harsh-sin-citys-buzz-2237331

Probably everyone at the grand opening with just be the kool aid drinkers of the stock.

Cost of revenue for the year ended December 31, 2015 was $6,924,402 as compared to $1,534,918 (351% increase) for the year ended December 31, 2014. Increases are due in large part to increases in sales as well as the fact that Hydro operated as a Surna subsidiary for twelve months during fiscal year 2015 and only five months during fiscal year 2014. Cost of revenue increased at a slightly higher rate than revenue due in part to costs related to installation contracts that Surna began in the second half of 2014. Surna has since trained several traditional HVAC installation companies on the Surna system and will cease installation and focus on core competencies in 2016. Surna saw gross margin percentages erode to 12% from 17% due primarily to the reduced margins from the installation business as well as higher manufacturing costs.


Says they plan to fix that problem this year.